| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Vascular Biology |
From the Cell Adhesion and Disease/Tumour Biology Laboratory (S.D.R., L.E.R., K.M.H.-D.), Cancer Research UK Clinical Centre, Queen Marys School of Medicine & Dentistry at Barts & The London, John Vane Science Centre, Charterhouse Square, London; Novartis Institute for Biomedical Research (L.W.), Angiogenesis Programme, Basel, Switzerland; and ImClone Systems Inc (D.J.H.), New York, NY.
Correspondence to Stephen D. Robinson, Cell Adhesion and Disease/Tumour Biology Laboratory, Cancer Research UK Clinical Centre, Queen Marys School of Medicine & Dentistry at Barts & The London, John Vane Science Centre, Charterhouse Square, London EC1M 6BQ, United Kingdom. E-mail s.d.robinson{at}cancer.org.uk
Objective ß3-integrin deficiency has been implicated in increasing levels of Flk-1 expression on endothelial cells and enhancing vascular endothelial growth factor (VEGF)-induced angiogenesis. We determined the role of ß3-integrin in mediating VEGF-Ainduced blood vessel permeability through Flk-1.
Methods and Results Using the Miles assay, we demonstrated that VEGF-Ainduced plasma leakage was enhanced in ß3-null mice when compared with wild-type controls. This was not caused by any changes in blood vessel structure (as detected by light or electron microscopy) or by changes in endothelial cellcell adhesion proteins (as determined by Western blot analysis, flow cytometry, and immunofluorescence). Circulating levels of VEGF, baseline blood vessel leakage, and leakage in response to an acute inflammatory stimulus were identical in wild-type and ß3-null mice. However, VEGF-Ainduced leakage was abolished in ß3-null mice by the inhibition of Flk-1, indicating that the elevated levels of Flk-1 on ß3-null endothelial cells enhance VEGF-Ainduced permeability.
Conclusions ß3-integrindeficiency increases the sensitivity of endothelial cells to VEGF-A by elevating Flk-1 expression and, as a consequence, enhances VEGF-Amediated permeability.
Blood vessels in ß3-integrindeficient mice are histologically normal and functionally intact. However, they express elevated levels of Flk-1 and are more sensitive than wild-type blood vessels to VEGF-Ainduced permeability, but not to permeability induced by acute inflammatory agents.
Key Words: ß3-integrin VEGF Flk-1 permeability endothelium
This article has been cited by other articles:
![]() |
N. S. Funa, V. Kriz, G. Zang, G. Calounova, B. Akerblom, J. Mares, E. Larsson, Y. Sun, C. Betsholtz, and M. Welsh Dysfunctional Microvasculature as a Consequence of Shb Gene Inactivation Causes Impaired Tumor Growth Cancer Res., March 1, 2009; 69(5): 2141 - 2148. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Silva, G. D'Amico, K. M. Hodivala-Dilke, and L. E. Reynolds Integrins: The Keys to Unlocking Angiogenesis Arterioscler Thromb Vasc Biol, October 1, 2008; 28(10): 1703 - 1713. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. N. Gavrilovskaya, E. E. Gorbunova, N. A. Mackow, and E. R. Mackow Hantaviruses Direct Endothelial Cell Permeability by Sensitizing Cells to the Vascular Permeability Factor VEGF, while Angiopoietin 1 and Sphingosine 1-Phosphate Inhibit Hantavirus-Directed Permeability J. Virol., June 15, 2008; 82(12): 5797 - 5806. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Weis, J. N. Lindquist, L. A. Barnes, K. M. Lutu-Fuga, J. Cui, M. R. Wood, and D. A. Cheresh Cooperation between VEGF and {beta}3 integrin during cardiac vascular development Blood, March 1, 2007; 109(5): 1962 - 1970. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H. Mahabeleshwar, W. Feng, D. R. Phillips, and T. V. Byzova Integrin signaling is critical for pathological angiogenesis J. Exp. Med., October 30, 2006; 203(11): 2495 - 2507. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, Z. Xiong, Y. Wu, W. Cai, J. R. Tseng, S. S. Gambhir, and X. Chen Quantitative PET Imaging of Tumor Integrin {alpha}v{beta}3 Expression with 18F-FRGD2 J. Nucl. Med., January 1, 2006; 47(1): 113 - 121. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |